BCAB
Sign in

BioAtla, Inc.

BCAB · OQB
Watching
—
Loading prices…
Daily prices

Rank vs the other stocks

Trading model · trial run, not placing orders yet
Hold
54thpercentile
WeakestStrongest

BCAB placed in the 54th percentile of the stocks being followed just after the open on . The trading model buys from the top of this list.

Model score
+0.09
Ranked

Old model

Guesses whether the price goes up or down. Latest call: Hold
Next day
↓ Down
1% confidence
Next 2 days
↓ Down
9% confidence

Made

Technical signals

Momentum, trend, volatility and volume from recent trading, as of
Momentum
RSI (14)
0.560
Stochastic %K (14)
0.907
Stochastic %D (14)
0.416
Trend
Price vs SMA (20)
0.244
Price vs EMA (26)
0.137
Price vs WMA (20)
0.243
Volatility
Bollinger %B (20/2)
1.167
Bollinger Bandwidth (20/2)
0.366
ATR % (14)
0.160
Volume
OBV change (20)
0.147
Money Flow Index (14)
0.642
Chaikin Money Flow (20)
−0.070
Returns & Statistics
Return (1)
0.330
Return (2)
0.232
Overnight gap
0.138

Technical signals for BCAB

Computed from recent prices and volume, as of . The models read these alongside the other signals. 100% of them have enough price history to compute; a 0 with low coverage usually means "not enough history yet", not a real reading.

Momentum

Oscillators that gauge how strongly and how fast the price has been moving — used to spot overbought/oversold conditions and shifts in drive.

RSI (7)
Relative Strength Index: 0–1 scale of recent gains vs losses. Above ~0.7 is 'overbought' (may be due to cool off); below ~0.3 'oversold'.
0.7007
RSI (14)
Relative Strength Index: 0–1 scale of recent gains vs losses. Above ~0.7 is 'overbought' (may be due to cool off); below ~0.3 'oversold'.
0.5602
RSI (21)
Relative Strength Index: 0–1 scale of recent gains vs losses. Above ~0.7 is 'overbought' (may be due to cool off); below ~0.3 'oversold'.
0.4977
Stochastic %K (14)
Where the close sits within its recent high–low range (0 = at the low, 1 = at the high).
0.9074
Stochastic %D (14)
A 3-day smoothing of Stochastic %K — the slower signal line.
0.4156
Stochastic %K (9)
Where the close sits within its recent high–low range (0 = at the low, 1 = at the high).
0.9074
Stochastic %D (9)
A 3-day smoothing of Stochastic %K — the slower signal line.
0.4421
Stochastic RSI (14)
RSI rescaled to where it sits in its own recent range (0–1) — a more sensitive overbought/oversold reading.
1.0000
Williams %R (14)
Like the Stochastic, the close's position in the recent range (0 = low, 1 = high).
0.9074
CCI (20)
Commodity Channel Index: how far price is from its average, squashed to about −1…+1. High = unusually strong, low = unusually weak.
0.9456
CCI (40)
Commodity Channel Index: how far price is from its average, squashed to about −1…+1. High = unusually strong, low = unusually weak.
0.6165
Rate of Change (5)
Log return over the lookback — simple momentum (positive = up).
0.2290
Rate of Change (10)
Log return over the lookback — simple momentum (positive = up).
0.1310
Rate of Change (20)
Log return over the lookback — simple momentum (positive = up).
0.1445
KDJ %K (9)
Smoothed position of the close in its recent range (0–1).
0.4399
KDJ %D (9)
A further smoothing of KDJ %K.
0.3119
KDJ %J (9)
The fast, sensitive leg of KDJ — exaggerates turns.
0.6017
Ultimate Oscillator (7/14/28)
Buying pressure blended across short, medium and long windows (0–1).
0.5254
True Strength Index (25/13)
Double-smoothed momentum, about −1…+1 (positive = upward drive).
−0.1286

Trend

Moving-average and directional measures of which way the price is trending and how strong that trend is.

Price vs SMA (10)
How far the close is above (+) or below (−) its simple moving average, as a fraction.
0.2736
Price vs SMA (20)
How far the close is above (+) or below (−) its simple moving average, as a fraction.
0.2443
Price vs SMA (50)
How far the close is above (+) or below (−) its simple moving average, as a fraction.
−0.0495
Price vs SMA (100)
How far the close is above (+) or below (−) its simple moving average, as a fraction.
−0.3705
Price vs SMA (200)
How far the close is above (+) or below (−) its simple moving average, as a fraction.
−0.6859
Price vs EMA (12)
How far the close is above/below its exponential moving average (weights recent prices more).
0.2220
Price vs EMA (26)
How far the close is above/below its exponential moving average (weights recent prices more).
0.1371
Price vs EMA (50)
How far the close is above/below its exponential moving average (weights recent prices more).
−0.0896
Price vs EMA (200)
How far the close is above/below its exponential moving average (weights recent prices more).
−0.8192
Price vs WMA (20)
How far the close is above/below its weighted moving average.
0.2429
PPO (12/26/9)
Percentage Price Oscillator — MACD expressed as a percent so it compares across stocks. Positive = short-term momentum above long-term.
−0.0694
PPO Signal (12/26/9)
The smoothed signal line of the PPO.
−0.1014
PPO Histogram (12/26/9)
PPO minus its signal line — momentum of the momentum.
0.0320
ADX (14)
Trend strength on a 0–1 scale (direction-agnostic). Higher = a stronger trend.
0.1456
+DI (14)
Strength of upward directional movement (0–1).
0.2359
−DI (14)
Strength of downward directional movement (0–1).
0.1510
Aroon Up (25)
How recently a new high was made (1 = just now).
0.0400
Aroon Down (25)
How recently a new low was made (1 = just now).
0.2000
Aroon Oscillator (25)
Aroon Up minus Down — positive favours an uptrend.
−0.1600
Parabolic SAR distance
How far price is from the trailing stop-and-reverse level, as a fraction of price.
0.3529
Parabolic SAR side
+1 when price is above the SAR (uptrend), −1 below.
1.0000
Vortex +VI (14)
Strength of upward trend movement (centred at 0).
−0.0668
Vortex −VI (14)
Strength of downward trend movement (centred at 0).
−0.2811
Vortex difference (14)
+VI minus −VI — positive favours an uptrend.
0.2143
MA slope (50/20)
The recent slope of a moving average (positive = rising trend).
−0.3153

Volatility

How much the price is swinging around — wide bands and high readings mean larger, riskier moves.

Bollinger %B (20/2)
Where price sits within its Bollinger Bands (0 = lower band, 1 = upper). Above 1 or below 0 is an extended move.
1.1672
Bollinger Bandwidth (20/2)
How wide the bands are relative to price — bigger means more volatile.
0.3661
ATR % (14)
Average True Range as a percent of price — typical daily swing size.
0.1597
Keltner position (20/10/2)
Where price sits within its Keltner Channel (0–1).
0.7642
Keltner width (20/10/2)
Width of the Keltner Channel relative to price.
0.7071
Donchian position (20)
Where price sits within its recent high–low channel (0–1).
0.7606
Donchian width (20)
Width of the recent high–low channel relative to price.
0.4656
Realized volatility (10)
Standard deviation of recent daily returns — how jumpy the stock has been.
0.1310
Realized volatility (20)
Standard deviation of recent daily returns — how jumpy the stock has been.
0.1031
Realized volatility (60)
Standard deviation of recent daily returns — how jumpy the stock has been.
0.1458
Chaikin Volatility (10/10)
Whether the daily high–low range is expanding (+) or contracting (−).
−0.1873
Ulcer Index (14)
A drawdown-based stress measure — higher means deeper/longer dips from recent highs.
20.5513

Volume

Whether trading activity is confirming the price move — money flowing in or out, and unusually heavy or light volume.

OBV change (20)
On-Balance Volume trend — net volume flowing in (+) or out (−).
0.1468
Money Flow Index (14)
A volume-weighted RSI (0–1). High = strong buying pressure.
0.6425
Chaikin Money Flow (20)
Buying vs selling pressure weighted by volume (−1…+1).
−0.0699
Money Flow Multiplier
Where the close finished in the bar's range, the building block of accumulation/distribution (−1…+1).
0.7222
Accum/Dist change (20)
Recent change in the Accumulation/Distribution line (buying vs selling pressure).
−0.0699
Price vs VWAP (20)
How far the close is above/below the rolling volume-weighted average price.
0.2221
Force Index (13)
Return times relative volume — the push behind a move.
0.5129
Ease of Movement (sign) (14)
+1 when price rose easily on light volume, −1 when it fell easily.
1.0000
Ease of Movement (z) (14)
How unusual today's ease-of-movement is vs recent days.
1.9987
Volume Rate of Change (14)
Log change in volume vs n days ago — a volume surge/lull.
1.6514
Volume Rate of Change (25)
Log change in volume vs n days ago — a volume surge/lull.
0.9232
Relative Volume (z) (20)
How many standard deviations today's volume is above/below its recent average.
0.1935
Relative Volume (z) (50)
How many standard deviations today's volume is above/below its recent average.
−0.3408
Relative Volume (20)
Today's volume vs its recent average (log scale; >0 = above).
0.1199
Relative Volume (50)
Today's volume vs its recent average (log scale; >0 = above).
−2.1140

Returns & Statistics

Recent returns over several horizons plus statistical shape (skew, fat tails, drawdown, risk-adjusted return).

Return (1)
Log return over the horizon (positive = up).
0.3295
Return (2)
Log return over the horizon (positive = up).
0.2320
Return (3)
Log return over the horizon (positive = up).
0.2513
Return (5)
Log return over the horizon (positive = up).
0.2290
Return (10)
Log return over the horizon (positive = up).
0.1310
Return (20)
Log return over the horizon (positive = up).
0.1445
Overnight gap
Open vs the prior close — overnight move.
0.1382
Intraday range
High minus low as a fraction of price — the day's swing.
0.2105
True range
True range (gap-aware swing) as a fraction of price.
0.3099
Return skew (20)
Asymmetry of recent returns — negative means crash-prone tails.
1.4634
Return skew (60)
Asymmetry of recent returns — negative means crash-prone tails.
−0.2741
Return kurtosis (20)
Fat-tailedness of recent returns — high means jumpy/extreme moves.
4.7948
Return kurtosis (60)
Fat-tailedness of recent returns — high means jumpy/extreme moves.
8.4729
Downside deviation (20)
Volatility of only the negative returns — pure downside risk.
0.0553
Downside deviation (60)
Volatility of only the negative returns — pure downside risk.
0.1096
Max drawdown (20)
Largest peak-to-trough drop over the window, as a fraction.
0.2264
Max drawdown (60)
Largest peak-to-trough drop over the window, as a fraction.
0.6914
Return/risk (20)
Average return divided by its volatility — recent risk-adjusted return.
0.0701
Return/risk (60)
Average return divided by its volatility — recent risk-adjusted return.
−0.0779
Return persistence (20)
Whether up days tend to follow up days (+) or reverse (−).
−0.1458
Return persistence (60)
Whether up days tend to follow up days (+) or reverse (−).
−0.1794
Price z-score (20)
How many standard deviations the price is from its recent average.
2.6013
Price z-score (50)
How many standard deviations the price is from its recent average.
−0.1217
Return z-score (20)
How unusual the latest return is vs recent returns.
3.1271
Return z-score (50)
How unusual the latest return is vs recent returns.
2.1525

Latest signals

Loading signals…

About BioAtla, Inc.

BioAtla, Inc., a clinical-stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead clinical stage product candidates include mecbotamab vedotin (BA3011), a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for treating undifferentiated… BioAtla, Inc., a clinical-stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead clinical stage product candidates include mecbotamab vedotin (BA3011), a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for treating undifferentiated pleomorphic sarcoma and non-small cell lung cancer (NSCLC); and ozuriftabmab vedotin (BA3021), a CAB ADC to treat melanoma and oropharyngeal squamous cell carcinoma. The company is also developing Evalstotug (BA3071), a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for treating melanoma, renal cell carcinoma, colorectal cancer, and NSCLC; BA3182, a bispecific candidate to treat adenocarcinomas; BA3361, a CAB-Nectin-4-ADC for treating tumors; BA3142, a dual-CAB T-cell engager targeting B7-H3, a protein expressed on various solid tumors; and preclinical candidate for CAB-Nectin 4 x CAB-CD3. The company was founded in 2007 and is headquartered in San Diego, California.
Sector
Healthcare
Industry
Biotechnology
Exchange
OQB
Currency
USD

News

No recent news about BCAB.

Locations

BioAtla, Inc. — GLEIF legal address
Canada
72% match

Where the company has offices, plants and other sites. Used to judge supply-chain and regional risk.